EGFR activation can increase dimer PKM2 expression and induce translocation of dimer PKM2 into the nucleus, where PKM2 acts both as a protein kinase and a transcriptional coactivator for HIF-1α in tumor tissues (He et al., 2014; Azoitei et al., 2016). Here, PKM is linked to neoplasm.